Howard CB - Search Results

1

Bispecific Antibody-Functionalized Upconversion Nanoprobe.

He H, Howard CB, Chen Y, Wen S, Lin G, Zhou J, Thurecht KJ, Jin D. He H, et al. Among authors: howard cb. Anal Chem. 2018 Mar 6;90(5):3024-3029. doi: 10.1021/acs.analchem.7b05341. Epub 2018 Feb 22. Anal Chem. 2018. PMID: 29443500

2

Biosensing made easy with PEG-targeted bi-specific antibodies.

Raftery LJ, Grewal YS, Howard CB, Jones ML, Shiddiky MJ, Carrascosa LG, Thurecht KJ, Mahler SM, Trau M. Raftery LJ, et al. Among authors: howard cb. Chem Commun (Camb). 2016 Apr 28;52(33):5730-3. doi: 10.1039/c6cc01916a. Chem Commun (Camb). 2016. PMID: 27045479

3

Overcoming Instability of Antibody-Nanomaterial Conjugates: Next Generation Targeted Nanomedicines Using Bispecific Antibodies.

Howard CB, Fletcher N, Houston ZH, Fuchs AV, Boase NR, Simpson JD, Raftery LJ, Ruder T, Jones ML, de Bakker CJ, Mahler SM, Thurecht KJ. Howard CB, et al. Adv Healthc Mater. 2016 Aug;5(16):2055-68. doi: 10.1002/adhm.201600263. Epub 2016 Jun 10. Adv Healthc Mater. 2016. PMID: 27283923

4

Recent Advances in the Generation of Antibody-Nanomaterial Conjugates.

Sivaram AJ, Wardiana A, Howard CB, Mahler SM, Thurecht KJ. Sivaram AJ, et al. Among authors: howard cb. Adv Healthc Mater. 2018 Jan;7(1). doi: 10.1002/adhm.201700607. Epub 2017 Sep 29. Adv Healthc Mater. 2018. PMID: 28961378 Review.

5

Enhanced delivery of siRNA to triple negative breast cancer cells in vitro and in vivo through functionalizing lipid-coated calcium phosphate nanoparticles with dual target ligands.

Tang J , Howard CB , Mahler SM , Thurecht KJ , Huang L , Xu ZP . Tang J , et al. Among authors: howard cb. Nanoscale. 2018 Mar 1;10(9):4258-4266. doi: 10.1039/c7nr08644j. Nanoscale. 2018. PMID: 29436549

6

RNA interference to enhance radiation therapy: Targeting the DNA damage response.

Ratnayake G, Bain AL, Fletcher N, Howard CB, Khanna KK, Thurecht KJ. Ratnayake G, et al. Among authors: howard cb. Cancer Lett. 2018 Dec 28;439:14-23. doi: 10.1016/j.canlet.2018.09.011. Epub 2018 Sep 18. Cancer Lett. 2018. PMID: 30240587 Review.

7

Modulating Targeting of Poly(ethylene glycol) Particles to Tumor Cells Using Bispecific Antibodies.

Cui J, Ju Y, Houston ZH, Glass JJ, Fletcher NL, Alcantara S, Dai Q, Howard CB, Mahler SM, Wheatley AK, De Rose R, Brannon PT, Paterson BM, Donnelly PS, Thurecht KJ, Caruso F, Kent SJ. Cui J, et al. Among authors: howard cb. Adv Healthc Mater. 2019 May;8(9):e1801607. doi: 10.1002/adhm.201801607. Epub 2019 Mar 14. Adv Healthc Mater. 2019. PMID: 30868751

8

Multifunctional lipid-coated calcium phosphate nanoplatforms for complete inhibition of large triple negative breast cancer via targeted combined therapy.

Tang J, Li B, Howard CB, Mahler SM, Thurecht KJ, Wu Y, Huang L, Xu ZP. Tang J, et al. Among authors: howard cb. Biomaterials. 2019 Sep;216:119232. doi: 10.1016/j.biomaterials.2019.119232. Epub 2019 May 31. Biomaterials. 2019. PMID: 31195300

9

Cellular Targeting of Bispecific Antibody-Functionalized Poly(ethylene glycol) Capsules: Do Shape and Size Matter?

Song D, Cui J, Ju Y, Faria M, Sun H, Howard CB, Thurecht KJ, Caruso F. Song D, et al. Among authors: howard cb. ACS Appl Mater Interfaces. 2019 Aug 14;11(32):28720-28731. doi: 10.1021/acsami.9b10304. Epub 2019 Aug 1. ACS Appl Mater Interfaces. 2019. PMID: 31369234

10

Polymer design and component selection contribute to uptake, distribution & trafficking behaviours of polyethylene glycol hyperbranched polymers in live MDA-MB-468 breast cancer cells.

Simpson JD, Ediriweera GR, Howard CB, Fletcher NL, Bell CA, Thurecht KJ. Simpson JD, et al. Among authors: howard cb. Biomater Sci. 2019 Nov 1;7(11):4661-4674. doi: 10.1039/c9bm00957d. Epub 2019 Aug 30. Biomater Sci. 2019. PMID: 31469127

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

122 results

Search Page